Management of Pain Possible for Childhood Vaccinations

Published Online: Thursday, August 16, 2012
Follow Pharmacy_Times:
Pain associated with childhood vaccination is currently undertreated, even though there are number of pain-relieving strategies that could be employed. Many health care providers argue, however, that they are currently too pressed for time to implement these strategies.

To determine whether there was enough time available for pain management within each vaccination appointment, researchers at the University of Toronto conducted a prospective naturalistic study at 8 urban outpatient primary care clinics and published their results in the March-April 2012 edition of the Clinical Journal of Pain. The researchers tracked the waiting time of children in 405 appointments from clinic arrival to first vaccine administered.

Their results showed that the mean wait time until first vaccination was 41.6 minutes, with a range from 7 to 132 minutes. There was a statistically significant difference among the clinics for wait times, which explains the wide range of data. These results suggest that, contrary to the perception of some health care providers, there is adequate time available to implement pain management strategies for children undergoing vaccination.

The researchers note that health care providers and parents should be educated regarding the benefits of pain management interventions and how to put evidence-based strategies into practice.

To read more articles in this watch, click:
Muscle Relaxants in Rheumatoid Arthritis
Self-Management Demonstrated in Migraine Patients


Related Articles
It is compulsory for pharmacists to counsel all patients receiving opioids, evaluate the potential benefit of a naloxone reversal device, and contact the opioid prescriber if such a device is deemed appropriate.
Used alongside antidepressants, OTC analgesics and anti-inflammatories purchased from pharmacies may effectively treat patients with depression without increasing their risk of adverse events.
The transdermal buprenorphine manufacturer has launched an awareness campaign to address specific knowledge gaps among pharmacists that pertain to opioids.
The FDA is reviewing a Biologics License Application for the first pediatric combination vaccine designed to help protect against 6 diseases.
Latest Issues
$auto_registration$